MOH — authorised 15 August 2014
- Marketing authorisation holder: BIOGEN IDEC INC
- Status: likely_approved
MOH authorised Plegridy on 15 August 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 15 August 2014.
BIOGEN IDEC INC holds the Israeli marketing authorisation.